# Haemonetics to acquire OpSens for $253M

Haemonetics Corporation announced a definitive agreement to acquire all outstanding shares of OpSens, Inc. for CAD $2.90 per share in an all-cash transaction valued at approximately USD $253 million. OpSens provides fiber optic sensor technology for interventional cardiology.

- Type: Acquisition
- Announced: 2023-10-10
- Value: $253.0M
- Status: announced
- Products: sensor-guided guidewires, pressure guidewires, fiber optic sensors
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Haemonetics](https://endata.com/companies/47664.md) (acquirer)
- [OpSens](https://endata.com/companies/73119.md) (target)

## Sources

- [haemonetics.gcs-web.com](https://haemonetics.gcs-web.com/news-releases/news-release-details/haemonetics-corporation-announces-definitive-agreement-acquire/), 2023-10-10: "Haemonetics Corporation and OpSens, Inc. today announced that they have entered into a definitive agreement under which Haemonetics will acquire all outstanding shares of OpSens for CAD $2.90 per share in an all-cash transaction representing a fully diluted equity value of approximately USD $253 mil"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.